Trovagene Using Bio-Rad Digital PCR System for Trans-Renal Pancreatic Cancer MDx - GenomeWeb
Trovagene Using Bio-Rad Digital PCR System for Trans-Renal Pancreatic Cancer MDx GenomeWeb By Ben Butkus A Trovagene official this week disclosed that the company is using Bio-Rad's QX100 Droplet Digital PCR system for a non-invasive, urine-based molecular test it is developing to detect and monitor the progression of pancreatic cancer.